Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2 V617F Mutation

Maria Pagoni, Maria Garofalaki, Irene Tziotziou, Evaggelia Nikolou, Stamatis Karakatsanis, Ioannis Tsonis, Katerina Zoi, Ioannis Baltathakis, Dimitrios Karakasis, Nikolaos Harhalakis

Blood (2014) 124 (21): 1844.

https://doi.org/10.1182/blood.V124.21.1844.1844

Published: 2014

Journal Articles

Double Umbilical Cord Blood Transplantation Offers Stable Donor Engraftment and The Prospect Of Cure In Adult Patients With High-Risk Hematologic Malignancies

Ioannis Baltathakis, Fotios Panitsas, Anna Komitopoulou, Ifigeneia Tzannou, Stavros Gigantes, Spyridoula Vasileiou, Zoi Poulopoulou, Maria Garofalaki, Eirini Tziotziou, Maria-Eleni Karatza, Eirini Grispou, John Apostolidis, Nikolaos Harhalakis, Dimitrios Karakassis

Blood (2013) 122 (21): 5516.

https://doi.org/10.1182/blood.V122.21.5516.5516

Published: 2013

Journal Articles

Prognostic Significance of Detection of Minimal Residual Disease by Multiparametric Flow Cytometry Before Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia,

Fotios P Panitsas, Ioannis Baltathakis, Ioannis Kakkas, MD, Stavros Gigantes, Anna Komitopoulou, Panagiotis Oikonomopoulos, Ifigeneia Tzannou, Eirini Grigoriou, Artemisia Balta, Aliki Vourtsi, Maria Skertsou, John Apostolidis, MD, DMs, MSc, Aikaterini Psarra, Chryssa Papasteriades, Dimitrios Karakassis, MD, Nikolaos Harhalakis

Blood (2011) 118 (21): 4116.

https://doi.org/10.1182/blood.V118.21.4116.4116

Published: 2011

Journal Articles

Immune Reconstitution After Double Umbilical Cord Blood Transplantation in Adults without In Vivo T Cell Depletion of the Graft.

Aikaterini Manaka, MD, Ioannis Baltathakis, MD, Ifigenia Tzannou, MD, Ioannis Kakkas, MD, Zoe Poulopoulou, Marilena Karatza, Maria Garofalaki, Irini Bika, Irini Tziotziou, Marina Papageorgiou, Spyridoula Vassiliou, John Apostolidis, MD, DMs, MSc, Dimitri Karakasis, MD, Nicholas Harhalakis, MD

Blood (2010) 116 (21): 1246.

https://doi.org/10.1182/blood.V116.21.1246.1246

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Using An Intravenous Busulfan Based Myeloablative Conditioning without Total Body Irradiation for Pediatric Patients with Acute Lymphoblastic Leukemia

Eugene Goussetis, MD, Anna Paisiou, MD, Ioulia Peristeri, MD, Vassiliki Kitra, MD, George Vessalas, MD, Maria N Dimopoulou, MD, Ioannis Baltathakis, MD, Stelios Graphakos, MD

Blood (2010) 116 (21): 3547.

https://doi.org/10.1182/blood.V116.21.3547.3547

Published: 2010

Journal Articles

The Combination of the Proteasome Inhibitor Bortezomib with Doxorubicin and Dexamethasone (PAD Regimen) as Front-Line Therapy In Newly Diagnosed, High-Risk Multiple Myeloma: Results of a Phase II Prospective Multicenter Study

Ioannis Baltathakis, Evangelos Terpos, Sosana Delimpasi, Konstantinos Liapis, Fotios Panitsas, Efstathios Kastritis, Anna Christoforidou, Anastasia Pouli, Konstantinos Tsatalas, Meletios A. Dimopoulos, Nikolaos Harhalakis

Blood (2010) 116 (21): 3052.

https://doi.org/10.1182/blood.V116.21.3052.3052

Published: 2010

Journal Articles

The Combination of Bortezomib, Doxorubicin, and Dexamethasone (PAD) Is an Effective Regimen for High Risk, Newly Diagnosed, Patients with Multiple Myeloma, Reduces Bone Resorption and Normalizes Angiopoietin-1 to Angiopoietin-2 Ratio.

Evangelos Terpos, Sosana Delimpasi, Konstantinos Anargyrou, Ioannis Baltathakis, Efstathios Kastritis, Anna Christoforidou, Konstantinos Tsionos, Konstantinos Tsatalas, Emmanuel Nikiforakis, Meletios A. Dimopoulos, Nikolaos Harhalakis

Blood (2007) 110 (11): 3596.

https://doi.org/10.1182/blood.V110.11.3596.3596

Published: 2007

Journal Articles

Weekly High-Dose Cidofovir Is an Effective Treatment for Symptomatic BK Virus (BKV)-Associated Hemorrhagic Cystitis (HC) after Allogeneic Stem Cell Transplantation (Allo-SCT).

Ioannis Baltathakis, MD, Michael Michael, MD, Eirini Grispou, PHD, Georgia Kourti, MD, Maria Bouzani, MD, Maria Anagnostopoulou, MD, John Apostolidis, MD, Dimitrios Karakassis, MD, Nicholas Harhalakis, MD, Olga Paniara, MD, Emmanuel Nikiforakis, MD

Blood (2006) 108 (11): 5306.

https://doi.org/10.1182/blood.V108.11.5306.5306

Published: 2006

NARROW

Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2 V617F Mutation

Double Umbilical Cord Blood Transplantation Offers Stable Donor Engraftment and The Prospect Of Cure In Adult Patients With High-Risk Hematologic Malignancies

Prognostic Significance of Detection of Minimal Residual Disease by Multiparametric Flow Cytometry Before Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia,

Immune Reconstitution After Double Umbilical Cord Blood Transplantation in Adults without In Vivo T Cell Depletion of the Graft.

Allogeneic Hematopoietic Stem Cell Transplantation Using An Intravenous Busulfan Based Myeloablative Conditioning without Total Body Irradiation for Pediatric Patients with Acute Lymphoblastic Leukemia

The Combination of the Proteasome Inhibitor Bortezomib with Doxorubicin and Dexamethasone (PAD Regimen) as Front-Line Therapy In Newly Diagnosed, High-Risk Multiple Myeloma: Results of a Phase II Prospective Multicenter Study

The Combination of Bortezomib, Doxorubicin, and Dexamethasone (PAD) Is an Effective Regimen for High Risk, Newly Diagnosed, Patients with Multiple Myeloma, Reduces Bone Resorption and Normalizes Angiopoietin-1 to Angiopoietin-2 Ratio.

Weekly High-Dose Cidofovir Is an Effective Treatment for Symptomatic BK Virus (BKV)-Associated Hemorrhagic Cystitis (HC) after Allogeneic Stem Cell Transplantation (Allo-SCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only